115 related articles for article (PubMed ID: 3779710)
1. Antitumor immune response to colorectal cancer antigen detected by the leukocyte adherence inhibition test (LAI) in groups at high risk for colorectal cancer.
Shani A; Fink A; Bass D; Gottesfeld F; Becker S; Levy E; Bentwich Z; Rozen P; Fireman Z; Hallak A
Cancer Detect Prev; 1986; 9(5-6):485-90. PubMed ID: 3779710
[TBL] [Abstract][Full Text] [Related]
2. [Screening for colorectal neoplasms].
Shani A; Rozen P; Fink A; Bass D; Levy E; Fireman Z; Gottesfeld F; Baker S; Fraizer D; Bentwich Z
Harefuah; 1990 Jan; 118(2):66-70. PubMed ID: 2179072
[TBL] [Abstract][Full Text] [Related]
3. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
Wagner T; Peschel U; Heydrich D; Ritter U
Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
[TBL] [Abstract][Full Text] [Related]
4. Limited value of leukocyte adherence inhibition in screening for colorectal neoplasia in high-risk groups.
Shani A; Rozen P; Fink A; Bass D; Fraser D; Bentwich Z
Cancer Detect Prev; 1989; 13(5-6):311-6. PubMed ID: 2743352
[TBL] [Abstract][Full Text] [Related]
5. Colonoscopy: a review of its yield for cancers and adenomas by indication.
Rex DK
Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
[TBL] [Abstract][Full Text] [Related]
6. [Screening for colorectal cancer and polyps].
Krieger Y; Fraser D; Odes HS; Krugliak P; Fraser GM
Harefuah; 1992 Mar; 122(6):354-6, 408. PubMed ID: 1582622
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions.
Shkolnik T; Livni E; Reshef R; Lachter J; Eidelman S
Am J Gastroenterol; 1987 Dec; 82(12):1275-8. PubMed ID: 3318403
[TBL] [Abstract][Full Text] [Related]
8. Immunological reactivity to soluble tumour extracts (STE) in gastrointestinal tumours and related risk groups.
Storch H; Raabe F; Krahl R; Liebe S; Hambsch K; Fischer H
Arch Geschwulstforsch; 1982; 52(1):57-61. PubMed ID: 7082132
[TBL] [Abstract][Full Text] [Related]
9. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
10. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
12. [Prevention and early detection of colorectal carcinoma by endoscopic examinations].
Porschen R; Schmiegel W
Z Gastroenterol; 1998 May; 36(5):403-14. PubMed ID: 9654708
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
Mounielou PM; Clemente F; Estival A; Ribet A
Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
[TBL] [Abstract][Full Text] [Related]
14. Risk factors in asymptomatic subjects screened for colorectal cancer.
Griffiths EK; Shapira DV
Cancer Detect Prev; 1990; 14(6):647-50. PubMed ID: 2257563
[TBL] [Abstract][Full Text] [Related]
15. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of different stool tests for the detection of cancer of the colon].
Vogel T; Driemel C; Hauser A; Hansmann A; Lange S; Jonas M; Möslein G
Dtsch Med Wochenschr; 2005 Apr; 130(14):872-7. PubMed ID: 15800820
[TBL] [Abstract][Full Text] [Related]
18. A comparison of tube leukocyte adherence inhibition assay and standard physical methods for diagnosing colorectal cancer.
Ayeni AO; Thomson DM; MacFarlane JK; Daly D
Cancer; 1981 Oct; 48(8):1855-62. PubMed ID: 7026024
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
20. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
